Lys254
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.0.1
Powered by Cell Signaling Technology
Home > Sumoylation Site Page: > Lys254  -  ELK1 (human)

Site Information
EVkVEGPkEELEVAG   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 3982501

In vivo Characterization
Methods used to characterize site in vivo:
electrophoretic mobility shift ( 1 ) , immunoprecipitation ( 1 ) , mutation of modification site ( 1 , 2 ) , western blotting ( 1 , 2 )
Disease tissue studied:
adrenal cancer ( 2 ) , pheochromocytoma ( 2 ) , neuroblastoma ( 1 )
Relevant cell line - cell type - tissue:
Balb/c(10)1 (fibroblast) ( 2 ) , HeLa (cervical) ( 2 ) , PC-12 (chromaffin) ( 2 ) , SH-SY5Y (neural crest) ( 1 )

Downstream Regulation
Effects of modification on ELK1:
intracellular localization ( 1 , 2 ) , sumoylation ( 1 )
Effects of modification on biological processes:
cell differentiation, inhibited ( 2 ) , transcription, induced ( 1 )

References 

1

Kelle D, Kırımtay K, Selçuk E, Karabay A (2019) Elk1 affects katanin and spastin proteins via differential transcriptional and post-transcriptional regulations. PLoS One 14, e0212518
30789974   Curated Info

2

Salinas S, et al. (2004) SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1. J Cell Biol 165, 767-73
15210726   Curated Info